A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients
NCT00002448 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2005-06-24
Summary
The purpose of this study is to examine how the immune systems of HIV-infected patients react to 2 anti-HIV drug combinations.
Conditions
- HIV Infections
Interventions
- DRUG
-
Ritonavir
- DRUG
-
Efavirenz
- DRUG
-
Saquinavir
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Mark Holodniy
-
Joseph John
-
Ronald Mitsuyasu
Study Design
- Purpose
- TREATMENT
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-10-31
Countries
- United States
Study Locations
More Related Trials
-
A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs
NCT00002162 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)
NCT00100048 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients
NCT01638650 ·Status: COMPLETED ·Phase: PHASE1
-
Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
NCT00112047 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment
NCT00005118 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients
NCT00002229 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
NCT00002378 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
NCT00924898 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)
NCT00293267 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002440 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
NCT00006208 ·Status: UNKNOWN ·Phase: PHASE3
-
A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults
NCT00242879 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
NCT00043888 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
NCT00004585 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)
NCT00293254 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
NCT02607956 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants
NCT05184452 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors
NCT00002361 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)
NCT00745823 ·Status: TERMINATED ·Phase: PHASE3
-
A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient
NCT00002184 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease
NCT00002397 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients
NCT00002190 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination
NCT00002416 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
NCT00002168 ·Status: COMPLETED ·Phase: NA
-
A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
NCT00002382 ·Status: COMPLETED ·Phase: PHASE3